Targeted cancer therapy systems:: an in silico study of radiohalogenated ligands in the estrogen receptor and the synthesis of a molecular toolkit for the fabrication of customizable nanoparticles.
Chemotherapy is often limited by off-target toxicity and the development of multi-drug resistance in response to treatment. Strategies which reduce off-target toxicity by passively or actively targeting cancer cells may improve the efficacy of chemotherapy. Herein, two projects relating to targeted...
| Published: |
|
|---|---|
| Online Access: | http://hdl.handle.net/2047/d20018709 |